logo

For the Inventor, By the Inventor

Praha, Czechoslovakia

Hana Dvorakova

This inventor holds 2 USPTO granted patents. Top assignees: Ceskoslovenska Akademie Ved, Institute of Organic Chemistry and Biochemistry, Rega Stichting, V.z.w.. Active years: 1992-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hana Dvorakova. Retrieved from https://idiyas.com/inventor/hana-dvorakova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 135(Granted Patents)


Location History:

  • Prague, CZ (1992)
  • Praha, CZ (2000)

Company Filing History:

goldMedal1 out of 242 
 
Ceskoslovenska Akademie Ved
 patents
silverMedal1 out of 50 
 
Institute of Organic Chemistry and Biochemistry
 patents
bronzeMedal1 out of 21 
 
Rega Stichting, V.z.w.
 patents
where one patent can have more than one assignee

Years Active: 1992-2000

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6057305 - Antiretroviral enantiomeric nucleotide analogs (2000-05-02),
2. 5130427 - (2R)-2-[di(2-propyl)phosphonylmethoxy]-3-p-to (1992-07-14),

Title: The Innovative Contributions of Hana Dvorakova

Introduction

Hana Dvorakova is a prominent inventor based in Praha, Czech Republic. She has made significant contributions to the field of antiviral pharmaceutical compositions, particularly through her innovative patents. With a total of 2 patents, her work has been instrumental in advancing treatments for retroviral infections.

Latest Patents

Dvorakova's latest patents include groundbreaking inventions such as antiretroviral enantiomeric nucleotide analogs. These resolved enantiomers are useful in antiviral pharmaceutical compositions aimed at treating retroviral infections. Another notable invention is the compound (2R)-2-[di(2-propyl)phosphonylmethoxy]-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane. This compound can be utilized for producing (S)-N-(3-hydroxy-2-phosphonylmethoxypropyl) derivatives of heterocyclic purine and pyrimidine bases, which exhibit antiviral activity.

Career Highlights

Throughout her career, Dvorakova has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences and Rega Stichting. Her research has focused on developing innovative solutions to combat viral infections, showcasing her dedication to improving public health.

Collaborations

Dvorakova has collaborated with notable professionals in her field, including Antonin Holy and Erik Desire DeClercq. These partnerships have further enhanced her research and contributed to the success of her inventions.

Conclusion

Hana Dvorakova's contributions to antiviral research and her innovative patents highlight her role as a leading inventor in the pharmaceutical field. Her work continues to inspire advancements in the treatment of retroviral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…